A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+metastatic breast cancer Meeting Abstract
| Authors: | Krop, I. E.; Beeram, M.; Modi, S.; Rabbee, N.; Girish, S.; Tibbitts, J.; Holden, S. N.; Lutzker, S. G.; Burris, H. A. |
| Abstract Title: | A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+metastatic breast cancer |
| Meeting Title: | 14th European Cancer Conference (ECCO 14) |
| Journal Title: | EJC Supplements |
| Volume: | 5 |
| Issue: | 4 |
| Meeting Dates: | 2007 Sep 23-27 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2007-09-01 |
| Start Page: | 219 |
| Language: | English |
| ACCESSION: | WOS:000250204000731 |
| DOI: | 10.1016/s1359-6349(07)70880-7 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 2118 - 14th European Cancer Conference (ECCO 14) - SEP 23-27, 2007 - Barcelona, SPAIN - "Source: Wos" |
